The respiratory syncytial virus (RSV) vaccine produced strong immune responses in older adults during its first two seasons of use, according to a new study.

Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental A trio of respiratory illnesses — flu, COVID-19 and RSV — is sweeping the U.S. and leaving a trail of coughing and aching ...

"Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut ...

However, sales of some key drugs like Prevnar, Xeljanz and Ibrance and new RSV vaccine, Abrysvo declined in the quarter. Pfizer's COVID revenues include direct sales and alliance revenues from its ...

BURLINGAME, CA, UNITED STATES, February 4, 2025 /EINPresswire / -- The Dual Chamber Prefilled Syringes Market is estimated to reach approximately USD 184.05 million in 2025 and is projected to ...

Pfizer's vaccine against respiratory syncytial virus, or RSV, saw $198 million in revenue for the fourth quarter, down 62% from the year-earlier period. The shot, known as Abrysvo, entered the ...

That shot, Abrysvo, brought in $198 million in the quarter, missing expectations by more than $300 million. Pfizer’s RSV vaccine has struggled to compete with one from GSK in a market that now ...

On the flip side, vaccines Prevnar and Abrysvo underperformed expectations. Pfizer expects $1B hit from IRA's Part D redesign and no major M&A in 2025 RSV vaccine Abrysvo specifically floundered ...

$10.8 billion invested in internal research and development projects, and Approximately $300 million invested in business development transactions. Returned capital directly to shareholders ...

US FDA approves AbbVie-Pfizer's treatment for intra-abdominal infections Robert F. Kennedy Jr., President Donald Trump's pick for health secretary, moved closer to securing the top health job on ...

Pregnant women can now get the maternal RSV vaccine, Abrysvo, for free under the National Immunisation Program (NIP), alongside ones for influenza and whooping cough. Abrysvo is available for ...

Canada anticipates at least two new products; nirsevimab, a long-acting monoclonal antibody, and an RSV stabilized pre-fusion subunit protein vaccine for pregnant women and people (Pfizer RSVpreF ...